Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma J Zhao, AX Chen, RD Gartrell, AM Silverman, L Aparicio, T Chu, ... Nature medicine 25 (3), 462-469, 2019 | 725 | 2019 |
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma BJ Gill, DJ Pisapia, HR Malone, H Goldstein, L Lei, A Sonabend, J Yun, ... Proceedings of the National Academy of Sciences 111 (34), 12550-12555, 2014 | 303 | 2014 |
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma AM Sonabend, IV Ulasov, MA Tyler, AA Rivera, JM Mathis, MS Lesniak Stem cells 26 (3), 831-841, 2008 | 300 | 2008 |
Convection-enhanced delivery AM Mehta, AM Sonabend, JN Bruce Neurotherapeutics 14 (2), 358-371, 2017 | 293 | 2017 |
Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133+ Glioma Stem Cells to Temozolomide Therapy IV Ulasov, S Nandi, M Dey, AM Sonabend, MS Lesniak Molecular medicine 17, 103-112, 2011 | 244 | 2011 |
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma P Kumthekar, CH Ko, T Paunesku, K Dixit, AM Sonabend, O Bloch, M Tate, ... Science translational medicine 13 (584), eabb3945, 2021 | 195 | 2021 |
Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors AE Andaloussi, AM Sonabend, Y Han, MS Lesniak Glia 54 (6), 526-535, 2006 | 176 | 2006 |
Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype L Lei, AM Sonabend, P Guarnieri, C Soderquist, T Ludwig, S Rosenfeld, ... PloS one 6 (5), e20041, 2011 | 168 | 2011 |
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo MA Tyler, IV Ulasov, AM Sonabend, S Nandi, Y Han, S Marler, J Roth, ... Gene therapy 16 (2), 262-278, 2009 | 156 | 2009 |
Newly diagnosed glioblastoma: a review on clinical management RV Lukas, DA Wainwright, E Ladomersky, S Sachdev, AM Sonabend, ... Oncology (Williston Park, NY) 33 (3), 91, 2019 | 144 | 2019 |
Ultrasound-mediated delivery of paclitaxel for glioma: a comparative study of distribution, toxicity, and efficacy of albumin-bound versus cremophor formulations DY Zhang, C Dmello, L Chen, VA Arrieta, E Gonzalez-Buendia, JR Kane, ... Clinical cancer research 26 (2), 477-486, 2020 | 142 | 2020 |
Prevention of ventriculostomy-related infections with prophylactic antibiotics and antibiotic-coated external ventricular drains: a systematic review AM Sonabend, Y Korenfeld, C Crisman, N Badjatia, SA Mayer, ... Neurosurgery 68 (4), 996-1005, 2011 | 136 | 2011 |
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial J Fares, AU Ahmed, IV Ulasov, AM Sonabend, J Miska, C Lee-Chang, ... The Lancet Oncology 22 (8), 1103-1114, 2021 | 126 | 2021 |
Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm H Ding, EF Douglass Jr, AM Sonabend, A Mela, S Bose, C Gonzalez, ... Nature communications 9 (1), 1471, 2018 | 116 | 2018 |
Frailty in geriatric glioblastoma patients: a predictor of operative morbidity and outcome M Cloney, R D'Amico, J Lebovic, M Nazarian, BE Zacharia, MB Sisti, ... World neurosurgery 89, 362-367, 2016 | 116 | 2016 |
A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies PD Chang, HR Malone, SG Bowden, DS Chow, BJA Gill, TH Ung, ... American Journal of Neuroradiology 38 (5), 890-898, 2017 | 114 | 2017 |
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial F Nassiri, V Patil, LS Yefet, O Singh, J Liu, RMA Dang, TN Yamaguchi, ... Nature medicine 29 (6), 1370-1378, 2023 | 105 | 2023 |
Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas AL Baldock, S Ahn, R Rockne, S Johnston, M Neal, D Corwin, ... PLoS One 9 (10), e99057, 2014 | 99 | 2014 |
Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status AL Baldock, K Yagle, DE Born, S Ahn, AD Trister, M Neal, SK Johnston, ... Neuro-oncology 16 (6), 779-786, 2014 | 98 | 2014 |
Anti–PD-1 induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 cytotoxic T cells G Rao, K Latha, M Ott, A Sabbagh, A Marisetty, X Ling, D Zamler, ... Clinical Cancer Research 26 (17), 4699-4712, 2020 | 91 | 2020 |